GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Panacos Pharmaceuticals, Inc. (PANC) [hlAlert]

Rating:
Buy PANC
down 99.98 %

Panacos Pharmaceuticals, Inc. (PANC) rated Buy

Posted on: Friday,  Oct 26, 2007  9:25 AM ET by Caris & Company

Caris & Company rated Buy Panacos Pharmaceuticals, Inc. (OTCBB: PANC) on 10/26/2007, when the stock price was $2.52.
Since then, Panacos Pharmaceuticals, Inc. has lost 99.98% as of 08/07/2015's recent price of $0.00.
If you would have followed this Caris & Company's recommendation on PANC, you would have lost 99.98% of your investment in 2842 days.

Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/26/2007 9:25 AM Buy
None
2.52 3.50
as of 8/27/2015
1 Week   
1 Month up  400.00 %
3 Months up  400.00 %
1 YTD down  -80.76 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/25/2007 9:25 AM Hold
None
1.90 3.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy